LSIA
BMY icon

LaSalle St. Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

LaSalle St. Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Buy
19,519
+101
+0.5% +$5.89K 0.17% 104
2025
Q4 		$1.05M Buy
+19,418
New +$934K 0.17% 96

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LaSalle St. Investment Advisors's BMY Position: Q1 2026 in Review

LaSalle St. Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.52% in Q1 2026, buying an estimated $5.89K and bringing the position to 19,519 shares worth $1.18M. The position accounts for 0.17% of the portfolio, ranked #104.

LaSalle St. Investment Advisors first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • LaSalle St. Investment Advisors held 19,519 shares of Bristol-Myers Squibb worth $1.18M as of Q1 2026.
  • LaSalle St. Investment Advisors bought 101 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.89K.
  • Bristol-Myers Squibb made up 0.17% of LaSalle St. Investment Advisors's portfolio in Q1 2026, its #104 holding.
  • LaSalle St. Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.